These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 3284075)
1. Is the new specific monoclonal radioimmunoassay for cyclosporine of value in liver transplantation? Gunson BK; Jones SR; Maclean S; Neuberger J; McMaster P Transplant Proc; 1988 Apr; 20(2 Suppl 2):323-9. PubMed ID: 3284075 [No Abstract] [Full Text] [Related]
2. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function: comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies. Rosano TG; Pell MA; Freed BM; Dybas MT; Lempert N Transplant Proc; 1988 Apr; 20(2 Suppl 2):330-8. PubMed ID: 3284076 [No Abstract] [Full Text] [Related]
3. Cyclosporine monitoring with polyclonal and specific monoclonal antibodies during episodes of renal allograft dysfunction. Holt DW; Marsden JT; Johnston A; Taube DH Transplant Proc; 1989 Feb; 21(1 Pt 2):1482-4. PubMed ID: 2652475 [No Abstract] [Full Text] [Related]
4. New Zealand multicentre comparison of monoclonal (Sandimmun) versus polyclonal (cyclosporine-RIA) radioimmunoassays for cyclosporine blood monitoring. Cooke R; Wilson T; Tisch G; Rawlins J; Neale TJ Transplant Proc; 1989 Feb; 21(1 Pt 2):1478-81. PubMed ID: 2652474 [No Abstract] [Full Text] [Related]
5. Monoclonal antibodies for the radioimmunoassay of cyclosporine. Marsden JT; Johnston A; Holt DW Transplant Proc; 1988 Apr; 20(2 Suppl 2):319-22. PubMed ID: 3284074 [No Abstract] [Full Text] [Related]
6. Monitoring of cyclosporine blood levels with polyclonal and monoclonal assays during episodes of renal graft dysfunction. Martinez L; Foradori A; Vaccarezza A; Martinez P; Rodriguez L Transplant Proc; 1989 Feb; 21(1 Pt 2):1490-1. PubMed ID: 2652479 [No Abstract] [Full Text] [Related]
7. A prospective study of cyclosporine monitoring in renal transplantation. Lindholm A Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388 [No Abstract] [Full Text] [Related]
8. Cyclosporine A nephrotoxicity in liver graft recipients: determination of nephrotoxic cyclosporine blood concentrations in liver graft recipients as defined by the HPLC and RIA tests. Hamilton G; Mühlbacher F; Roth E; Steininger R; Wolf I; Schindler J; Wolosczuk W; Piza F Transplant Proc; 1987 Oct; 19(5):4045-8. PubMed ID: 3313996 [No Abstract] [Full Text] [Related]
9. Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine. Chapman JR; Morris PJ Transplant Proc; 1985 Aug; 17(4 Suppl 1):254-60. PubMed ID: 3895664 [No Abstract] [Full Text] [Related]
10. Performance of the Sandoz radioimmunoassays for cyclosporine. Holt DW; Marsden JT; Fashola TO; Johnston A Transplant Proc; 1990 Jun; 22(3):1155-9. PubMed ID: 2349678 [No Abstract] [Full Text] [Related]
11. Biologic assessment of cyclosporine in serum of kidney transplant patients. Heidecke CD; Nicolaus C; Stadler J; Adolf J; Florack G; Bollschweiler E; Hoelscher M Transplant Proc; 1988 Apr; 20(2 Suppl 2):494-8. PubMed ID: 3284096 [No Abstract] [Full Text] [Related]
12. Cyclosporine blood level measurements with mono- and polyclonal antibodies during clinical renal transplantation. Foradori AC; Martinez L; Loveluck A; Correa L; Rodriguez L Transplant Proc; 1989 Feb; 21(1 Pt 2):1486. PubMed ID: 2652477 [No Abstract] [Full Text] [Related]
13. Cyclosporine levels in whole blood. Comparison of the polyclonal Sandoz Ciclosporin Radioimmunoassay Kit with the specific antibody in the new Sandimmun Kit. Jones SR; Gunson B; McLean S; McMaster P; Ratcliffe JG Transplantation; 1988 May; 45(5):991-2. PubMed ID: 3285548 [No Abstract] [Full Text] [Related]
14. Lymphocyte parameters in liver graft recipients receiving prophylactic OKT3 or conventional triple therapy. Hamilton G; Mühlbacher F; Steininger R; Havel M; Kreuzer S; Laengle F; Piza F Transplant Proc; 1989 Feb; 21(1 Pt 2):2255-6. PubMed ID: 2652732 [No Abstract] [Full Text] [Related]
15. Clinical and experimental studies with cyclosporine in renal transplantation. Kahan BD; van Buren CT; Flechner SM; Jarowenko M; Yasumura T; Rogers AJ; Yoshimura N; LeGrue S; Drath D; Kerman RH Surgery; 1985 Feb; 97(2):125-40. PubMed ID: 3881837 [No Abstract] [Full Text] [Related]
16. Improvement of renal function after conversion from cyclosporine only to prednisolone-azathioprine followed by late-onset graft failure in renal transplant patients. Tegzess AM; van Son WJ; Beelen JM; Sluiter WJ; Meijer S; Slooff MJ Transplant Proc; 1987 Feb; 19(1 Pt 3):2000-4. PubMed ID: 3547904 [No Abstract] [Full Text] [Related]
17. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements. Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692 [No Abstract] [Full Text] [Related]
18. The significance of tumour necrosis factor serum levels in organ transplantation. White DJ; Obers A Eur Cytokine Netw; 1990; 1(4):245-9. PubMed ID: 2104246 [TBL] [Abstract][Full Text] [Related]
19. Prophylactic ATG or OKT3 in liver transplantation in the presence of contraindications to cyclosporine (CyA) or azathioprine (AZA). Gugenheim J; Samuel D; Chaland P; Saliba F; Bismuth H Transplant Proc; 1989 Feb; 21(1 Pt 2):2257. PubMed ID: 2652733 [No Abstract] [Full Text] [Related]
20. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants. Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055 [No Abstract] [Full Text] [Related] [Next] [New Search]